Case Study: Arcturus Therapeutics achieves 30% increase in research productivity with Benchling

Enhancing Research Productivity by 30%

Arcturus Therapeutics, a leader in RNA medicines collaborating with Janssen and Ultragenyx, develops therapies for rare diseases but was held back by fragmented tools: no standardized molecular design platform, a legacy ELN with only 20–30% adoption and a 10‑day lag to record experiments, and scattered sequence and data repositories that prevented effective collaboration and knowledge capture.

By implementing Benchling’s cloud-based Molecular Biology and Lab Notebook, Arcturus centralized sequences, protocols and experimental records, enabling same‑day data entry, collaborative design and full experimental traceability. Adoption rose to about 90%, scientists regained more than 30% of their day for research, and overall research productivity increased by 30%, accelerating decision-quality results.

Arcturus Therapeutics

Christian Cobaugh

Director of Drug Discovery